Pavel Hamet
#95,659
Most Influential Person Now
Canadian academic
Pavel Hamet's AcademicInfluence.com Rankings
Pavel Hametmedical Degrees
Medical
#1528
World Rank
#1876
Historical Rank
Pharmacology
#157
World Rank
#196
Historical Rank
Pavel Hametphilosophy Degrees
Philosophy
#5215
World Rank
#7958
Historical Rank
Logic
#2530
World Rank
#3535
Historical Rank
Download Badge
Medical Philosophy
Pavel Hamet's Degrees
- Doctorate Medicine McGill University
- PhD Pharmacology McGill University
Why Is Pavel Hamet Influential?
(Suggest an Edit or Addition)According to Wikipedia, Pavel Hamet is a doctor, researcher, editor, administrator and teacher in Quebec. Working in the medical field, he is the Canada Research Chair in Predictive Genomics of hypertension and cardiovascular diseases. He is Professor of Medicine at the University of Montreal, Adjunct Professor of Experimental Medicine at McGill University, and visiting professor at the First Faculty of Medicine at Charles University, Prague, Czech Republic. He is currently Chief of Gene Medicine and member of the Endocrinology Services at the University of Montreal's Research Centre . He was designated president of the International Society of Pathophysiology from 2010 to 2014. Associated editor of the Journal of Hypertension, he is also a member of the Commission de l'éthique en science et en technologie of the Quebec government and president, chief of the scientific direction of Medpharmgene compagny.
Pavel Hamet's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (2008) (5018)
- Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009) (850)
- The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013) (625)
- Artificial intelligence in medicine. (2017) (543)
- Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. (2014) (503)
- A comprehensive view of sex-specific issues related to cardiovascular disease (2007) (479)
- Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. (2018) (473)
- Shanghai trial of nifedipine in the elderly (STONE). (1996) (438)
- Apoptosis in pressure overload-induced heart hypertrophy in the rat. (1996) (437)
- Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. (2016) (428)
- Awareness, treatment, and control of hypertension in Canada. (1997) (392)
- The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. (2010) (390)
- Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (2016) (388)
- 1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting (1993) (348)
- Early experience with laparoscopic approach for adrenalectomy. (1993) (346)
- Effect of native and synthetic atrial natriuretic factor on cyclic GMP. (1984) (339)
- Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes (2014) (322)
- Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. (2001) (317)
- Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds (2012) (297)
- Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial (2014) (266)
- Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes (2009) (265)
- Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. (2017) (264)
- Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. (2013) (264)
- Apoptosis in target organs of hypertension. (1995) (260)
- The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. (2012) (255)
- A catalog of genetic loci associated with kidney function from analyses of a million individuals (2019) (252)
- Lowering blood pressure reduces renal events in type 2 diabetes. (2009) (251)
- Distribution of blood pressure and hypertension in Canada and the United States. (2001) (247)
- Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome. (1999) (238)
- The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase (1985) (223)
- Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. (1997) (211)
- Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. (2009) (202)
- The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2014) (189)
- Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (2009) (187)
- Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON (2016) (185)
- Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels (2019) (183)
- Abnormalities in Growth Characteristics of Aortic Smooth Muscle Cells in Spontaneously Hypertensive Rats (1989) (178)
- Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2013) (177)
- Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. (1997) (172)
- The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (165)
- Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. (1992) (163)
- The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013) (159)
- Hypertension: genes and environment (1998) (155)
- Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics. (2013) (154)
- 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (152)
- The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. (2008) (151)
- Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases (2004) (145)
- The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. (2007) (145)
- Emergence of Sex Differences in Prevalence of High Systolic Blood Pressure: Analysis of a Longitudinal Adolescent Cohort (2006) (144)
- The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. (2011) (142)
- Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
- Atrial natriuretic factor-induced egression of cyclic guanosine 3':5'-monophosphate in cultured vascular smooth muscle and endothelial cells. (1989) (139)
- The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. (2009) (139)
- Cyclic GMP as mediator and biological marker of atrial natriuretic factor. (1986) (138)
- Rapid increase in plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man. (1985) (138)
- Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study (2014) (137)
- RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. (2006) (135)
- The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. (2006) (135)
- Influence of environmental temperature on the blood pressure of hypertensive patients in Montréal. (1991) (126)
- The angiotensin II type 1 receptor and receptor-associated proteins (2001) (126)
- Genes, maternal smoking, and the offspring brain and body during adolescence: Design of the Saguenay Youth Study (2007) (126)
- Milk- and soy-protein ingestion: acute effect on serum uric acid concentration. (1991) (124)
- Contemporary model for cardiovascular risk prediction in people with type 2 diabetes (2011) (123)
- Aberrant G‐protein coupled receptor expression in relation to adrenocortical overfunction (2009) (122)
- Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes (2015) (121)
- Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? (2000) (121)
- Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. (2001) (118)
- Arterial Pressure, Left Ventricular Mass, and Aldosterone in Essential Hypertension (2001) (116)
- ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia. (2014) (115)
- Effect of Chronic Infusion of Synthetic Atrial Natriuretic Factor (ANF 8-33) in Conscious Two-Kidney, One-Clip Hypertensive Rats (1985) (115)
- Genome-wide association study of kidney function decline in individuals of European descent (2014) (114)
- Genetics and genomics of depression. (2005) (111)
- Chronic Infusion of Low Doses of Atrial Natriuretic Factor (ANF Arg 101-Tyr 126) Reduces Blood Pressure in Conscious SHR without Apparent Changes in Sodium Excretion (1985) (108)
- Genetic determinants of hypertension: identification of candidate phenotypes. (2000) (106)
- Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. (2000) (105)
- Methyl xanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mesenteric artery preparation. (1977) (104)
- Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. (1997) (103)
- Cyclic GMP in cell function. (1988) (102)
- Cancer and hypertension. An unresolved issue. (1996) (101)
- Proteome Analysis and Functional Expression Identify Mortalin as an Antiapoptotic Gene Induced by Elevation of [Na+]i/[K+]i Ratio in Cultured Vascular Smooth Muscle Cells (2002) (100)
- Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. (2000) (100)
- Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
- Cushing's syndrome variants secondary to aberrant hormone receptors (2004) (96)
- Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. (1993) (95)
- High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. (2003) (95)
- Activation of cAMP signaling transiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase-3 (1999) (90)
- Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension. (2005) (89)
- Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome. (1998) (89)
- Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. (2010) (89)
- A Common Variant of the FTO Gene Is Associated With Not Only Increased Adiposity but Also Elevated Blood Pressure in French Canadians (2009) (87)
- Hyperaldosteronism and Hypertension: Ethnic Differences (2005) (87)
- Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria (2019) (86)
- The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. (2005) (85)
- Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension. (1999) (83)
- Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity. (1999) (81)
- The Impact of a Multidisciplinary Information Technology–Supported Program on Blood Pressure Control in Primary Care (2009) (80)
- Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. (1987) (80)
- Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study. (2016) (80)
- Genetics of the sleep-wake cycle and its disorders. (2006) (79)
- Intracellular Monovalent Ions as Second Messengers (2006) (77)
- Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE (2009) (77)
- Transforming growth factor beta 1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats. (1991) (77)
- Immunocytochemical localization of atrial natriuretic factor in the heart and salivary glands (2004) (74)
- Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study (2016) (73)
- Cushing syndrome with food-dependent periodic hormonogenesis. (1987) (71)
- Protection against necrosis but not apoptosis by heat-stress proteins in vascular smooth muscle cells: evidence for distinct modes of cell death. (1999) (70)
- The evaluation of the scientific evidence for a relationship between calcium and hypertension. (1995) (70)
- Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation o (1999) (70)
- Ubiquitous [Na+]i/[K+]i-Sensitive Transcriptome in Mammalian Cells: Evidence for Ca2+ i-Independent Excitation-Transcription Coupling (2012) (68)
- Inhibition of Na+,K+-ATPase by ouabain triggers epithelial cell death independently of inversion of the [Na+]i/[K+]i ratio. (2003) (68)
- Cardiotonic Steroids Differentially Affect Intracellular Na+ and [Na+]i/[K+]i-independent Signaling in C7-MDCK Cells* (2005) (68)
- Apoptosis in vascular smooth muscle cells: role of cell shrinkage. (1996) (66)
- Role of genomics on the path to personalized medicine. (2013) (66)
- Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent cushing's syndrome. (1999) (65)
- An increase in adenylate cyclase activity precedes DNA synthesis in cultured vascular smooth muscle cells (1984) (65)
- Characteristics of a new binding protein distinct from the kinase for guanosine 3':5'-monophosphate in rat platelets. (1980) (64)
- Free and Conjugated Plasma Catecholamines in Hypertensive Patients With and Without Pheochromocytoma (1980) (64)
- Impact of diabetes on crash risks of truck-permit holders and commercial drivers. (2000) (64)
- The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy. (2002) (62)
- The influence of dairy products on plasma uric acid in women (1995) (62)
- Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial (2010) (62)
- Apoptosis and vascular wall remodeling in hypertension. (1996) (62)
- Glomerular hyperfiltration in hypertensive African Americans. (2000) (61)
- Gene-environment interactions in hypertension (1999) (61)
- Is Hypertension a Case of Accelerated Aging of Cardiovascular Cells? (2001) (61)
- Proliferation and apoptosis of vascular smooth muscle in hypertension. (1995) (60)
- Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial (2018) (59)
- Na+/K+ pump and endothelial cell survival: [Na+]i/[K+]i-independent necrosis triggered by ouabain, and protection against apoptosis mediated by elevation of [Na+]i (2004) (59)
- c‐Fos Expression in Ouabain‐Treated Vascular Smooth Muscle Cells from rat Aorta: Evidence for an Intracellular‐Sodium‐Mediated, Calcium‐Independent Mechanism (2002) (59)
- Enhanced DNA synthesis in heart and kidney of newborn spontaneously hypertensive rats. (1986) (57)
- Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men. (1989) (57)
- Sucrose feeding during pregnancy and lactation elicits distinct metabolic response in offspring of an inbred genetic model of metabolic syndrome. (2007) (57)
- Genetics of pain, opioids, and opioid responsiveness. (2010) (56)
- Continuous Subcutaneous Insulin Infusion (Mill-Hill Infuser) Versus Multiple Injections (Medi-Jector) in the Treatment of Insulin-dependent Diabetes Mellitus and the Effect of Metabolic Control on Microangiopathy (1984) (55)
- The time window of apoptosis: a new component in the therapeutic strategy for cardiovascular remodeling. (1996) (55)
- Effects of Atrial Natriuretic Factor on Natriuresis and cGMP in Patients with Essential Hypertension (1987) (54)
- Vascular smooth muscle cell proliferation and its therapeutic modulation in hypertension. (1991) (53)
- Essential Hypertension with Low Conjugated Catecholamines Imitates Pheochromocytoma (1981) (53)
- Development of Hypertension and Kidney Hypertrophy in Transgenic Mice Overexpressing ARAP1 Gene in the Kidney (2006) (52)
- Cancer and hypertension: a potential for crosstalk? (1997) (51)
- Vascular smooth muscle cell hyper‐responsiveness to growth factors in hypertension (1988) (51)
- Genome-Wide Scan for Linkage to Obesity-Associated Hypertension in French Canadians (2005) (50)
- Systematic, Genome-Wide, Sex-Specific Linkage of Cardiovascular Traits in French Canadians (2008) (50)
- Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. (2013) (50)
- Cell volume and monovalent ion transporters: their role in cell death machinery triggering and progression. (2013) (49)
- Rat model of familial combined hyperlipidemia as a result of comparative mapping. (2004) (49)
- Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril. (2003) (49)
- Accelerated entry of aortic smooth muscle cells from spontaneously hypertensive rats into the S phase of the cell cycle. (1992) (48)
- Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling. (2006) (48)
- Interactions Among Calcium, Sodium, and Alcohol Intake As Determinants of Blood Pressure (1991) (48)
- Cell volume in vascular smooth muscle is regulated by bumetanide-sensitive ion transport. (1996) (48)
- Effect of N-terminal portion of pro-opiomelanocortin on aldosterone release by human adrenal adenoma in vitro. (1981) (48)
- Calcium-induced release from platelet membranes of fatty acids that modulate soluble guanylate cyclase. (1983) (47)
- Contrasting Effects of Hypoglycemia on Plasma Renin Activity and Cyclic Adenosine 3′, 5‐Monophosphate (Cyclic AMP) in Low Renin and Normal Renin Essential Hypertension (1976) (47)
- Inhibition of Na+,K+ pump affects nucleic acid synthesis and smooth muscle cell proliferation via elevation of the [Na+]i/[K+]i ratio: possible implication in vascular remodelling (2001) (47)
- Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. (2004) (46)
- Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. (2006) (46)
- Celastrol protects ischaemic myocardium through a heat shock response with up‐regulation of haeme oxygenase‐1 (2014) (46)
- HSP27 locus cosegregates with left ventricular mass independently of blood pressure. (1996) (46)
- Cyclic Nucleotides and Aggregation in Platelets of Spontaneously Hypertensive Rats (1978) (46)
- ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia. (2016) (46)
- In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene. (2001) (45)
- Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. (2009) (45)
- Inversion of the intracellular Na(+)/K(+) ratio blocks apoptosis in vascular smooth muscle cells by induction of RNA synthesis. (2000) (45)
- cAMP signaling inhibits dihydropyridine-sensitive Ca2+ influx in vascular smooth muscle cells. (1996) (45)
- Free and Conjugated Dopamine in Pheochromocytoma, Primary Aldosteronism and Essential Hypertension (1979) (44)
- Circulating forms and radioimmunoassay of atrial natriuretic factor. (1987) (44)
- Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats. (1993) (44)
- Effect of natural and synthetic atrial natriuretic factor on arterial blood pressure, natriuresis and cyclic GMP excretion in spontaneously hypertensive rats. (1985) (44)
- Epidemiological evidence of an interaction between calcium and sodium intake impacting on blood pressure. A Montréal study. (1992) (43)
- HCaRG, a Novel Calcium-regulated Gene Coding for a Nuclear Protein, Is Potentially Involved in the Regulation of Cell Proliferation* (2000) (43)
- Increased Transcription of a Major Stress Gene in Spontaneously Hypertensive Mice (1990) (43)
- Expression of hsp70 gene in lymphocytes from normotensive and hypertensive humans. (1992) (43)
- Liver membrane adenylate cyclase. Synergistic effects of anions on fluoride, glucagon, and guanyl nucleotide stimulation. (1975) (42)
- Studies of the elevated extracellular concentration of cyclic AMP in uremic man. (1975) (42)
- Cyclic GMP binding and cyclic GMP phosphodiesterase in rat platelets. (1978) (42)
- Impact of genetic and epigenetic factors from early life to later disease. (2008) (42)
- The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort study of adolescents (2013) (42)
- ANF stimulation of detergent‐dispersed particulate guanylate cyclase from bovine adrenal cortex (1986) (42)
- ANF in experimental congestive heart failure. (1988) (41)
- Multiple Quantitative Trait Loci for Blood Pressure Interacting Epistatically and Additively on Dahl Rat Chromosome 2 (2005) (41)
- Environmental and genetic contributions to diabetes. (2019) (41)
- Newborn and adult recombinant inbred strains: a tool to search for genetic determinants of target organ damage in hypertension. (1998) (41)
- Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma. (2009) (41)
- Genes of aging. (2003) (40)
- Predictors of Target Organ Damage in Hypertensive Blacks and Whites (2001) (40)
- Altered balance between cell replication and apoptosis in hearts and kidneys of newborn SHR. (1997) (40)
- Platelets, Growth Factors, and Vascular Smooth‐Muscle Cells in Hypertension and Diabetes (1993) (38)
- Diet-induced obesity delays cardiovascular recovery from stress in spontaneously hypertensive rats. (2004) (38)
- Atrial natriuretic factor: radioimmunoassay and effects on adrenal and pituitary glands. (1986) (38)
- Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (2018) (38)
- The heart as an endocrine gland. (1985) (37)
- Mapping of quantitative trait loci (QTL) of differential stress gene expression in rat recombinant inbred strains (2000) (37)
- NKCC1 and hypertension: a novel therapeutic target involved in the regulation of vascular tone and renal function (2010) (37)
- Life insurance: genomic stratification and risk classification (2013) (37)
- Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans. (2002) (37)
- Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (37)
- Genetic mapping of habitual substance use, obesity-related traits, responses to mental and physical stress, and heart rate and blood pressure measurements reveals shared genes that are overrepresented in the neural synapse (2012) (37)
- Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial (2017) (36)
- Abnormalities of Platelet Function in Hypertension and Diabetes (1985) (36)
- Endothelial Gata5 transcription factor regulates blood pressure (2015) (36)
- Dynamic genetic architecture of metabolic syndrome attributes in the rat. (2005) (36)
- Patient self-management of continuous subcutaneous insulin infusion. (1982) (35)
- Caspase‐Dependent Cell Death Mediates the Early Phase of Aortic Hypertrophy Regression in Losartan‐Treated Spontaneously Hypertensive Rats (2003) (35)
- The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. (2001) (35)
- Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes (2016) (35)
- Expression of ACTH receptor pathway genes in glucose‐dependent insulinotrophic peptide (GIP)‐dependent Cushing's syndrome (2006) (34)
- Prazosin Plasma Concentration and Blood Pressure Reduction (1982) (34)
- Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors. (1976) (34)
- Contribution of autosomal loci and the Y chromosome to the stress response in rats. (2000) (34)
- SARS–CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking (2021) (34)
- Catecholamine sulfates and platelet phenolsulfotransferase activity in essential hypertension. (1984) (33)
- Na+,K+ pump and Na+-coupled ion carriers in isolated mammalian kidney epithelial cells: regulation by protein kinase C. (1999) (33)
- Urinary and plasma cyclic adenosine 3',5'-monophosphate in patients with idiopathic edema. (1975) (33)
- Comparisons between C57BL/6J and A/J mice in motor activity and coordination, hole-poking, and spatial learning (2002) (32)
- HCaRG is a novel regulator of renal epithelial cell growth and differentiation causing G2M arrest. (2003) (32)
- Time- and dose dependent actions of cardiotonic steroids on transcriptome and intracellular content of Na+ and K+: a comparative analysis (2017) (32)
- Segment of Rat Chromosome 20 Regulates Diet-Induced Augmentations in Adiposity, Glucose Intolerance, and Blood Pressure (2003) (32)
- Salt and gene expression: evidence for [Na+]i/[K+]i-mediated signaling pathways (2015) (32)
- Bumetanide-sensitive Ion Fluxes in Vascular Smooth Muscle Cells: Lack of Functional Na+, K+, 2 Cl− Cotransport (1996) (32)
- Transcriptomic Changes Triggered by Hypoxia: Evidence for HIF-1α -Independent, [Na+]i/[K+]i-Mediated, Excitation-Transcription Coupling (2014) (32)
- Preparation of cyclic nucleotide antisera with thyroglobulin-cyclic nucleotide conjugates. (1980) (31)
- Heat stress genes in hypertension. (1990) (31)
- Single-channel analysis of the electrical response of bovine aortic endothelial cells to bradykinin stimulation: contribution of a Ca2(+)-dependent K+ channel. (1990) (31)
- The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study (2019) (30)
- Association of age-dependent height and bone mineral density decline with increased arterial stiffness and rate of fractures in hypertensive individuals (2015) (30)
- Extrarenal angiotensin-forming enzymes. (1983) (30)
- Abnormalities of platelet-derived growth factors in insulin-dependent diabetes. (1985) (29)
- Gender-specific genetic determinants of blood pressure and organ weight: pharmacogenetic approach. (2003) (28)
- Characterization of a cGMP-Response Element in the Guanylyl Cyclase/Natriuretic Peptide Receptor A Gene Promoter (2004) (28)
- The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing's syndrome. (2005) (28)
- Apoptosis in serum-deprived vascular smooth muscle cells: Evidence for cell volume-independent mechanism (2004) (27)
- Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study (2018) (27)
- Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1 (2017) (27)
- Plasma Cyclic Adenosine 3':5' ‐Monophosphate Response to Isoproterenol and Glucagon in Hyperkinetic Borderline (Labile) Hypertension (1976) (27)
- A genealogical study of essential hypertension with and without obesity in French Canadians. (2002) (27)
- Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline. (2020) (27)
- Key Considerations and Methods in the Study of Gene-Environment Interactions. (2016) (27)
- ATP-Induced Inhibition of Na+, K+, Cl− Cotransport in Madin-Darby Canine Kidney Cells: Lack of Involvement of Known Purinoceptor-Coupled Signaling Pathways (1999) (26)
- Effect of upright posture and isoproterenol infusion on cyclic adenosine monophosphate excretion in control subjects and patients with labile hypertension. (1973) (26)
- Analysis of the putative regulatory region of the gastric inhibitory polypeptide receptor gene in food-dependent Cushing’s syndrome (2004) (26)
- Increased Na(+)/H(+) exchanger isoform 1 activity in spontaneously hypertensive rats: lack of mutations within the coding region of NHE1. (2000) (26)
- Transcriptomic changes in Ca²⁺-depleted cells: Role of elevated intracellular [Na⁺]/[K⁺] ratio. (2015) (26)
- Episodic dopamine discharge in paroxysmal hypertension. Page's syndrome revisited. (1986) (25)
- Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes. (2019) (25)
- Artificial Intelligence and Machine Learning in Endocrinology and Metabolism: The Dawn of a New Era (2019) (25)
- The death of cardiotonic steroid‐treated cells: evidence of Na+i,K+i‐independent H+i‐sensitive signalling (2006) (25)
- PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study (2017) (25)
- Apoptosis in Cardiovascular Remodeling—Effect of Medication (2001) (25)
- Plasma adenosine 3',5'-cyclic monophosphate in human hypertension. (1974) (25)
- What matters in ADVANCE and ADVANCE‐ON (2012) (25)
- [Na+]i‐induced c‐Fos expression is not mediated by activation of the 5′‐promoter containing known transcriptional elements (2007) (24)
- Increased accumulation of hsp70 messenger RNA due to enhanced activation of heat-shock transcription factor in spontaneously hypertensive rats. (1991) (24)
- The Relationship between Adrenergic Nervous System and Renin in Labile Hyperkinetic Hypertension (1972) (24)
- Are plasma aldosterone surges in primary aldosteronism due to a loss of an inhibitory dopaminergic control? (1980) (24)
- Primary versus secondary events in hypertension. (1985) (24)
- Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes. (1993) (24)
- Effect of hypoglycemia on extracellular levels of cyclic AMP in man. (1975) (24)
- Platelets and vascular smooth muscle: abnormalities of phosphodiesterase, aggregation, and cell growth in experimental and human diabetes. (1983) (23)
- Search for intermediates of Na+,K+-ATPase-mediated [Na+]i/[K+]i-independent death signaling triggered by cardiotonic steroids. (2005) (23)
- Polygenic Overlap Between Kidney Function and Large Artery Atherosclerotic Stroke (2014) (23)
- Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage. (2005) (23)
- Hypertension Canada's 2016 CHEP Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention and Treatment of Hypertension (2016) (23)
- Regression of Neointimal Lesions in the Carotid Artery of Nifedipine-Treated SHR and WKY Rats: Possible Role of Apoptosis (2001) (23)
- Excitation-contraction coupling in resistance mesenteric arteries: evidence for NKCC1-mediated pathway. (2009) (23)
- NKCC1 and hypertension: Role in the regulation of vascular smooth muscle contractions and myogenic tone (2012) (22)
- Purinergic Modulation of Na+,K+,Cl− Cotransport and MAP Kinases is Limited to C11-MDCK Cells Resembling Intercalated Cells from Collecting Ducts (1999) (22)
- Dopamine Surges in Hyperadrenergic Essential Hypertension (1982) (22)
- Myogenic tone in mouse mesenteric arteries: evidence for P2Y receptor-mediated, Na+, K+, 2Cl− cotransport-dependent signaling (2009) (22)
- Abnormal expression and function of hormone receptors in adrenal Cushing's syndrome. (1998) (22)
- TA Repeat Variation, Npr1 Expression, and Blood Pressure: Impact of the Ace Locus (2003) (22)
- Regulation of caspase 3 and Fas in pressure overload‐induced left ventricular dysfunction (2004) (22)
- Genetic determinants of the stress response in cardiovascular disease. (2002) (22)
- Swelling rather than shrinkage precedes apoptosis in serum-deprived vascular smooth muscle cells (2012) (22)
- Death of ouabain-treated renal epithelial cells: evidence for p38 MAPK-mediated Nai+/Ki+-independent signaling (2009) (22)
- Hypertension with adrenal, genital, renal defects, and deafness. A new familial syndrome. (1973) (22)
- Effect of metoclopramide on plasma catecholamine release in essential hypertension (1985) (21)
- Congenic mapping of a blood pressure QTL on Chromosome 16 of Dahl rats (2002) (21)
- Pharmacogenomics of metabolic effects of rosiglitazone. (2008) (21)
- Genes of intracellular calcium metabolism and blood pressure control in primary hypertension. (1995) (20)
- Effect of plasma, serum and platelets from diabetics on DNA synthesis in cultured vascular smooth muscle cells. (1985) (20)
- Decrease of blood pressure in spontaneously hypertensive mice by heat treatment. (1990) (20)
- Identification of Hypertension-Related QTLs in African American Sib Pairs (2002) (20)
- 6. Recommendations on potassium, magnesium and calcium (1999) (20)
- Distinct quantitative trait loci for kidney, cardiac, and aortic mass dissociated from and associated with blood pressure in Dahl congenic rats (2006) (20)
- Complete inhibition of Na+, K+, Cl- cotransport in Madin-Darby canine kidney cells by PMA-sensitive protein kinase. (1998) (19)
- Altered beta-adrenergic regulation of Na-K-Cl cotransport in cultured smooth muscle cells from the aorta of spontaneously hypertensive rats. Role of the cytoskeleton network. (1995) (19)
- Cyclic GMP binding and phosphodiesterase: implication for platelet function. (1984) (18)
- The effect of Diamicron on the secretion and action of insulin. (1991) (18)
- Therapeutic Modulation of Growth-Promoting Activity in Platelets From Diabetics (1987) (18)
- Identification and chromosomal localization of ecogenetic components of electrolyte excretion (2002) (18)
- Na/K Pump and Intracellular Monovalent Cations: Novel Mechanism of Excitation–Transcription Coupling Involved in Inhibition of Apoptosis (2003) (18)
- Apoptosis vs. oncosis: role of cell volume and intracellular monovalent cations. (2004) (18)
- HCaRG increases renal cell migration by a TGF-α autocrine loop mechanism (2005) (18)
- Antihypertensive therapy debate: contribution from the Shanghai Trial Of Nifedipine in the Elderly (STONE) (1996) (18)
- Responses to tyramine and norepinephrine after imipramine and trazodone (1979) (18)
- The rapid decline of MTT reduction is not a marker of death signaling in ouabain-treated cells. (2006) (18)
- [Na+]i/[K+]i-independent death of ouabain-treated renal epithelial cells is not mediated by Na+,K+-ATPase internalization and de novo gene expression (2007) (17)
- Modest intracellular acidification suppresses death signaling in ouabain-treated cells (2005) (17)
- COMMD5/HCaRG Hooks Endosomes on Cytoskeleton and Coordinates EGFR Trafficking. (2018) (17)
- Enhanced growth-dependent expression of TGF beta 1 and hsp70 genes in aortic smooth muscle cells from spontaneously hypertensive rats. (1992) (17)
- Cardiac and renal hyperplasia in newborn spontaneously hypertensive rats. (1987) (17)
- Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (17)
- Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. (2015) (17)
- Cardiotonic steroids: novel mechanisms of Na+i-mediated and –independent signaling involved in the regulation of gene expression, proliferation and cell death (2005) (17)
- IX - 1993 Guidelines for management of mild hypertension. Memorandum from a WHO/ISH meeting (1993) (17)
- The death of ouabain-treated renal epithelial cells: evidence against anoikis occurrence (2008) (17)
- Current status of genome-wide scanning for hypertension (2007) (16)
- Renal Ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapy (2002) (16)
- Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome (2009) (16)
- Swelling-Induced K+ Fluxes in Vascular Smooth Muscle Cells are Mediated by Charybdotoxin-Sensitive K+ Channels (2001) (16)
- Intensification of medication and glycaemic control among patients with type 2 diabetes – the ADVANCE trial (2014) (16)
- Abnormality of calmodulin activity in hypertension. Evidence of the presence of an activator. (1988) (16)
- Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats. (1989) (16)
- The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome. (2016) (16)
- Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension. (1973) (16)
- The burden of blood pressure: where are we and where should we go? (2000) (16)
- Genetic determinants of emotionality and stress response in AcB/BcA recombinant congenic mice and in silico evidence of convergence with cardiovascular candidate genes. (2008) (16)
- Hormone receptor abnormalities in adrenal Cushing's syndrome. (1998) (16)
- Sibling resemblance of erythrocyte ion transporters in French-Canadian sibling-pairs affected with essential hypertension. (1999) (15)
- Biomarkers of vascular complications in type 2 diabetes. (2015) (15)
- HCaRG increases renal cell migration by a TGF-alpha autocrine loop mechanism. (2005) (15)
- Renal Effects of Immersion in Essential Hypertension (1994) (15)
- Effect of atrial natriuretic factor [ANF (Arg 101--Tyr 126)] on kallikrein and cyclic GMP in the renovascular hypertensive rat. (1985) (15)
- Effect of prolonged infusion of ANF in normotensive and hypertensive monkeys. (1989) (15)
- The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial (2021) (15)
- Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk (2016) (15)
- Can we use erythrocytes for the study of the activity of the ubiquitous Na+/H+ exchanger (NHE-1) in essential hypertension? (1998) (15)
- HCO3--Dependent Impact of Na+,K+,2Cl- Cotransport in Vascular Smooth Muscle Excitation-Contraction Coupling (2009) (15)
- Genes and hypertension: where we are and where we should go. (1999) (15)
- Resolving the composite trait of hypertension into its pharmacogenetic determinants by acute pharmacological modulation of blood pressure regulatory systems (2002) (14)
- Cyclic nucleotide phosphodiesterase and aggregation in platelets from diabetic rats. (1982) (14)
- Cyclic nucleotides in hypertension. (1980) (14)
- Increased Renal Epithelial Na Channel Expression and Activity Correlate With Elevation of Blood Pressure in Spontaneously Hypertensive Rats (2013) (14)
- The diversity of abnormal hormone receptors in adrenal Cushing's syndrome allows novel pharmacological therapies. (2000) (14)
- Prevention of hypertension and associated cardiovascular disease: a 1991 statement. Conclusions from a joint WHO/ISH meeting. (1992) (14)
- Characterization of a primate model of hypertension. The response of hypertensive and normotensive male vervets (Cercopithecus aethiops) to cold pressor stress, captopril administration, and acute bolus of atrial natriuretic factor. (1990) (14)
- [64] Platelet cGMP-binding phosphodiesterase (1988) (13)
- Recommendations on potassium , magnesium and calcium (1999) (13)
- Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension. (1989) (13)
- 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
- Morphology of renal afferent arterioles and glomeruli, heart weight, and blood pressure in primates. (2001) (13)
- Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes. (1988) (13)
- Shanghai trial of nifedipine in the elderly (1996) (13)
- The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE. (2019) (13)
- Effects and pharmacokinetics of bolus injections of atrial natriuretic factor in normal volunteers. (1988) (13)
- Atrial natriuretic peptide--cyclic GMP coupling and urinary sodium excretion during acute volume expansion in man. (1990) (12)
- Genetic hypertension is characterized by the abnormal expression of a gene localized in major histocompatibility complex HSP70. (1990) (12)
- Atrial natriuretic factor constitutes an intrinsic functional unit within superior cervical ganglia of the rat (1990) (12)
- Stress modulation by electrolytes in salt-sensitive spontaneously hypertensive rats. (1994) (12)
- Integrating genomics and transcriptomics with geo-ethnicity and the environment for the resolution of complex cardiovascular diseases. (2005) (12)
- HCaRG accelerates tubular repair after ischemic kidney injury. (2011) (12)
- GREBP, a cGMP-response Element-binding Protein Repressing the Transcription of Natriuretic Peptide Receptor 1 (NPR1/GCA)* (2010) (12)
- Central blood pressures in early chronic kidney disease: an analysis of CARTaGENE (2016) (12)
- The heart as an endocrine gland. (1987) (11)
- Posthumous reproduction with surplus in vitro fertilization embryos: a study exploring users' choices. (2014) (11)
- Hypertension in hyperthyroidism: is there an epinephrine connection? (1982) (11)
- Prevention of cardiovascular diseases in developing countries: agenda for action: statement from a WHO-ISH meeting in Beijing (1999) (11)
- A locus on chromosome 10 influences C-reactive protein levels in two independent populations (2007) (11)
- Decreased NKCC1 activity in erythrocytes from African Americans with hypertension and dyslipidemia. (2010) (11)
- Evaluating atrial natriuretic peptide-induced cGMP production by particulate guanylyl cyclase stimulation in vitro and in vivo. (1991) (11)
- [3H]-thymidine labelling of DNA triggers apoptosis potentiated by E1A-adenoviral protein (2003) (11)
- Evidence of an Altered In Vivo Vascular Cell Turnover in Spontaneously Hypertensive Rats and Its Modulation by Long-term Antihypertensive Treatment (2001) (11)
- Intrinsic factors involved in vascular smooth muscle cell proliferation in hypertension. (1991) (11)
- Debate: vascular remodelling. (1997) (11)
- Environmental stress and genes of hypertension. (1995) (11)
- Release of atrial natriuretic factor (ANF) induced by acute airway obstruction. (1989) (11)
- Chromosomal mapping of HCaRG, a novel hypertension-related, calcium-regulated gene. (2002) (11)
- Genetics of programmed cell death and proliferation. (2002) (11)
- Precision and costs of techniques for self-monitoring of serum glucose levels. (1984) (11)
- No effects of pantoprazole on the pharmacokinetics of rosuvastatin in healthy subjects (2016) (11)
- Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (11)
- Labile (Borderline) Hypertension—New Aspects of a Common Disorder (1975) (11)
- Replacement of (alpha)1-Na-K-ATPase of Dahl rats by Milan rats lowers blood pressure but does not affect its activity. (2001) (11)
- GENES OF STRESS IN EXPERIMENTAL HYPERTENSION (1994) (10)
- [Exposure to the risk of traffic accidents, a fundamental epidemiological parameter, and one difficult to measure]. (1991) (10)
- EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes (2019) (10)
- Novel double-congenic strain reveals effects of spontaneously hypertensive rat chromosome 2 on specific lipoprotein subfractions and adiposity. (2006) (10)
- Environmentally-Reguiated Genes of Hypertension (1996) (10)
- Receptor imaging with atrial natriuretic peptide. Part 1: High specific activity iodine-123-atrial natriuretic peptide. (1994) (10)
- Longitudinal analysis of motor activity and coordination, anxiety, and spatial learning in mice with altered blood pressure (2001) (10)
- AVAPROMISE: A randomized clinical trial for increasing adherence through behavioural modification in essential hypertension. (2002) (10)
- Regional sources of free and sulfoconjugated catecholamines in hypertension. (1984) (10)
- Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation. (1985) (10)
- Apolipoprotein E alleles and hypertension: controversy or lack of understanding? (2002) (9)
- Cardiotonic steroid-resistant α1-Na+,K+-ATPase rescues renal epithelial cells from the cytotoxic action of ouabain: evidence for a Nai+,Ki+-independent mechanism (2009) (9)
- Dual Effect of Adenosine on Vascular Smooth Muscle [3H]-Thymidine DNA Labeling: Receptor-Mediated Modulation of DNA Synthesis and Inhibition of Thymidine Uptake (2000) (9)
- Effects of Continuous Subcutaneous Insulin Infusion Versus Multiple Injections on Insulin Receptors in Insulin-Dependent Diabetics (1987) (9)
- Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene (2017) (9)
- Cyclic nucleotides in clinical pharmacology (1983) (9)
- Labetalol in Essential Hypertension (1980) (9)
- Effect of enalapril on renin, angiotensin converting enzyme activity, aldosterone and prostaglandins in patients with hypertension. (1985) (9)
- The hemodynamic relevance of free and conjugated dopamine in pheochromocytoma. (1982) (9)
- Environmentally-regulated genes of hypertension. (1996) (9)
- Activity of Cyclic AMP-Dependent Protein Kinase in Heart and Aorta of Spontaneously Hypertensive Rat (1980) (9)
- Hypertension-related, calcium-regulated gene (HCaRG/COMMD5) and kidney diseases: HCaRG accelerates tubular repair (2014) (8)
- Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats. (1984) (8)
- A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome (2010) (8)
- Tobacco smoking strongly modifies the association of prothrombin G20210A with undetermined stroke: consecutive survivors and population-based controls. (2015) (8)
- HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma. (2017) (8)
- Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study (2020) (8)
- HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma (2017) (8)
- Theophylline and bronchospasm. (1977) (8)
- Personalized Medicine: Interdisciplinary Perspective, World Tidal Wave, and Potential Growth for the Emerging Countries (2017) (8)
- Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation (2015) (8)
- Heat stress preconditioning does not protect renal epithelial Na(+),K(+),Cl(-) and Na(+),P(i) cotransporters from their modulation by severe heat stress. (1999) (8)
- Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial (2019) (8)
- Distinct plasma atrial natriuretic factor, renin and aldosterone responses to prolonged high-salt intake in hypertensive and normotensive rats. (1991) (7)
- Treatment of Refractory Hypertension with Minoxidil (1980) (7)
- Effects of dietary calcium on the development of salt hypertension in young and adult Dahl rats (1988) (7)
- The Na(+)/K(+)-ATPase as [K(+)](o) sensor: Role in cardiovascular disease pathogenesis and augmented production of endogenous cardiotonic steroids. (2006) (7)
- Predicting the Effects of Blood Pressure–Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes MellitusNovelty and Significance (2015) (7)
- Regional brain variations of cytochrome oxidase activity in spontaneously hypertensive mice (2004) (7)
- Differential linkage of triglyceride and glucose levels on rat chromosome 4 in two segregating rat populations. (2003) (7)
- 15 – Platelets in Hypertension and Peripheral Vascular Disease (1985) (7)
- Stimulation of rat platelet adenylate cyclase by an endogenous calcium-dependent protease-like activity. (1982) (7)
- Bends in the Coronary Arteries after Removal of Muscle Bridges (1968) (7)
- Biochemical mechanisms of atrial natriuretic factor action. (1989) (7)
- Plasma atrial natriuretic peptide during spontaneous bronchoconstriction in asthmatics (1995) (7)
- Genomic Determinants of Triglyceride and Cholesterol Distribution into Lipoprotein Fractions in the Rat (2014) (7)
- Cyclic nucleotides and calcium in platelets (1987) (6)
- Investigation of mechanism of p38 MAPK activation in renal epithelial cell from distal tubules triggered by cardiotonic steroids (2010) (6)
- The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial (2020) (6)
- Sex‐specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE‐ON study (2020) (6)
- The α1-Na/K Pump does not Mediate the Involvement of Ouabain in the Development of Hypertension in Rats (2002) (6)
- Economic Evaluation of a New Polygenic Risk Score to Predict Nephropathy in Adult Patients With Type 2 Diabetes. (2020) (6)
- Rapid activation of cAMP phosphodiesterase in rat platelets. (1983) (6)
- AMBULATORY BLOOD PRESSURE MONITORING. DISUCSSION (1996) (6)
- ALTERNATIVE SPLICING OF NATRIURETIC PEPTIDE A AND B RECEPTOR TRANSCRIPTS IN THE RAT BRAIN (1995) (6)
- Endothelial and myocyte apoptosis--role of angiotensin II. (2001) (6)
- ANALYSIS OF THE PUTATIVE PROMOTER REGION OF THE GIP RECEPTOR GENE (GIPR) IN GIP-DEPENDENT CUSHING'S SYNDROME (CS) (2002) (6)
- Cell biology of atrial natriuretic peptide. (1991) (6)
- Dynamic genetic linkage of intermediate blood pressure phenotypes during postural adaptations in a founder population. (2013) (6)
- ANF and Head-Out Water Immersion in Normotensive and Essential Hypertensive Pregnant Women (1992) (5)
- Dopamine discharge in orthostatic hypotension and paroxysmic hypertension; opposing aspects of dopamine action. (1983) (5)
- Once‐Daily Dosing of Acebutolol in Hypertension (1983) (5)
- Hypertension and diabetes. (1993) (5)
- Abnormal hsp70 gene expression: its potential key role in metabolic defects in hypertension. (1992) (5)
- Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial (2021) (5)
- CD36-deficient congenic strains show improved glucose tolerance and distinct shifts in metabolic and transcriptomic profiles (2012) (5)
- Catecholamine Sulfates and Platelet Phenolsulfotransferase (PST) Activity in Human Hypertension (1981) (5)
- Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials (2020) (5)
- A prospective comparison of four study designs used in assessing safety and effectiveness of drug therapy in hypertension management. (1997) (5)
- Antihypertensive efficacy of propranolol given twice daily. (1979) (5)
- Dopamine, extracellular cyclic AMP and sodium excretion (1977) (5)
- Atrial natriuretic factor in experimental and human hypertension. (1988) (5)
- Renal effects of immersion in essential hypertension. Carvedilol Study Group. (1994) (4)
- Altered Phosphorylation of RRXS*/T* Motif in Ouabain-Treated Renal Epithelial Cells is not Mediated by Inversion of the [Na+]i/[K+]i Ratio (2008) (4)
- Echocardiographic Measurements and Plasma Levels of Atrial Natriuretic Factor (1988) (4)
- A quantitative trait locus for aortic smooth muscle cell number acting independently of blood pressure: implicating the angiotensin receptor AT1B gene as a candidate. (2005) (4)
- The effects of sucrose meal on insulin requirement in IDDM and its modulation by acarbose. (1986) (4)
- Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals (2022) (4)
- Genetic basis of increased sensitivity to environmental stress in hypertension. (2016) (4)
- Effects of beta-adrenergic blockade on plasma cyclic AMP and blood sugar responses to glucagon and isoproterenol in man. (1976) (4)
- Contribution of the TNF alpha gene region of rat chromosome 20 to the body temperature response to endotoxin. (1999) (4)
- [Effects of phenylephrine on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential hypertensive patients]. (1988) (4)
- The atrial natriuretic factor in mild essential hypertension. (1987) (4)
- Characteristics of adenylate cyclase activity in pig coronary arteries. (1978) (4)
- Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes (2009) (4)
- Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertension. (1977) (4)
- Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies (2022) (4)
- Increase of calmodulin activator in hypertension. Modulation by dietary sodium and calcium. (1990) (4)
- In vivo measurement of atrial natriuretic peptide receptors using nuclear imaging. (1992) (4)
- GOAT: Genetic Output Analysis Tool: An open source GWAS and genomic region visualization tool (2016) (4)
- Future needs in exploration of gene-environment interactions. (2012) (4)
- Atrial natriuretic factor, the kidney and high blood pressure. (1989) (4)
- Rats Smooth Muscle Apoptosis During Vascular Regression in Spontaneously Hypertensive (1997) (4)
- Effect of atrial natriuretic factor and 8-bromo cyclic guanosine 3':5'-monophosphate on [3H]acetylcholine outflow from myenteric-plexus longitudinal muscle of the guinea pig. (1991) (4)
- Neurobehavioral evaluation of high blood pressure and low blood pressure mice (1999) (3)
- Genome-wide association study of kidney function decline in individuals of European descent: the CKDGen Consortium. (2015) (3)
- Cyclic nucleotides in pathophysiology. (1984) (3)
- Author response for "Response of 1,5‐anhydroglucitol to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial" (2019) (3)
- Angiotensin as a Cytokine Implicated in Accelerated Cellular Turnover (2004) (3)
- Primary hyperaldosteronism: a pituitary--adrenal dysfunction related to a new pituitary glycopeptide? (1982) (3)
- EXPRESSION OF ACTH RECEPTOR PATHWAY GENES IN GIP-DEPENDENT CUSHING’S SYNDROME (CS) (2002) (3)
- No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation-positive families. (2017) (3)
- [Physiological and physiopathological aspects of the atrial natriuretic factor]. (1987) (3)
- Suppression of Programmed Cell Death by Intracellular cAMP Is not Mediated by Expression of Genes Encoding an Inhibitor of Apoptosis (2002) (3)
- Hypertension in pregnancy: new recommendations for management. (1997) (3)
- Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials (2017) (3)
- Molecular origin of Na(+)/Li(+) exchanger: Evidence against the involvement of major cloned erythrocyte transporters. (2011) (3)
- Hypoglycemic effect of fenfluramine in insulin-treated diabetics. (1986) (3)
- Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial (2021) (3)
- Clinical relationships of cyclic GMP. (1994) (3)
- Catecholamines, cyclic AMP and renin in two contrasting forms of essential hypertension. (1977) (3)
- COMMD5 Inhibits Malignant Behavior of Renal Cancer Cells (2021) (3)
- The renin-angiotensin system: where do we stand, and what is the future? (2005) (3)
- 532 Priming of Stem Cells With Celastrol to Enhance Survival for Cell Therapy (2012) (3)
- Abstract 14198: Pre-Conditioning of Stem Cell With Celastrol to Enhance Their Therapeutical Potential (2011) (3)
- Atrial natriuretic factor (ANF) in experimental and human hypertension. (1987) (3)
- Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR, Issue III (2008) (3)
- PARTIAL CHARACTERISATION OF THE 5′ FLANKING REGION OF THE HUMAN GIP RECEPTOR (GIPR) GENE (2002) (3)
- INVESTIGATING CLINICALLY-DEFINED SUBSETS OF HYPERTENSION MAY FACILITATE THE SEARCH FOR ITS GENES: 1B.5 (2004) (3)
- Pharmacodynamic Effects of Bolus Administration of ANF in Normal Volunteers (1986) (3)
- The whole heart is an endocrine gland. (1987) (3)
- Addressing Provenance Issues in Big Data Genome Wide Association Studies (GWAS) (2016) (2)
- Pathophysiological aspects of cyclic nucleotides (1980) (2)
- Platelet cGMP-binding phosphodiesterase. (1988) (2)
- Dietary Fructose and Elevated Levels of Blood Pressure (2010) (2)
- ULTRASOUND MICRO-ELASTOGRAPHY: A NEW IMAGING MODALITY TO PHENOTYPE HYPERTENSION IN RAT MODELS (2007) (2)
- What is apoptosis and what is its relevance to vascular biology? (1999) (2)
- Prevention of hypertension and associated cardiovascular disease. A 1995 statement. Conclusions from a joint WHO/ISH Meeting. (1996) (2)
- Calcium antagonists and cancer: limitations of pros and cons. (1998) (2)
- Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension (2005) (2)
- Maternal smoking, genes and adolescent brain and body: The saguenay youth study (2009) (2)
- Increased inositol trisphosphate in erythrocytes of spontaneously hypertensive rats. (1990) (2)
- Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes. (2022) (2)
- Antiproliferative effect of brief exposure to cholera toxin in vascular smooth muscle cells: role of cAMP and protein kinase A. (2001) (2)
- TRUCK CRASH RISKS FOR DRIVERS WITH DIABETES ACCORDING TO THEIR TYPE OF TREATMENT (1998) (2)
- Effect of intravenous atrial natriuretic peptide on gas exchange in humans (1994) (2)
- Radio-Telemetry in Biomedical Research - Radio-Telemetry Blood Pressure Measurements in Animal Models of Hypertension, How It Revolutionized Hypertension Research (2011) (2)
- Polygenic risk scores predict diabetic complications and their response to therapy (2019) (2)
- Biochemical characteristics of a calmodulin-phosphodiesterase activator increased in spontaneously hypertensive mice and rats. (1994) (2)
- Long-term normalization of blood pressure in SHR and 1-kidney 1-clip rats by synthetic precursor of stable PAF analogue without systemic effects in normotensive rats. (2011) (2)
- Uromodulin in a Pathway Between Decreased Renal Urate Excretion and Albuminuria (2018) (2)
- Missing heritability or need for reality check of clinical utility in genomic testing? (2014) (2)
- Heat stress proteins in hypertension (1986) (2)
- Conjugation of catecholamines, a variable to be accounted for in human hypertension. (1980) (2)
- Unconjugated Hyperepinephrinemia: A Hallmark of Hypertension Imitating Pheochromocytoma? (1981) (2)
- Polygenic Risk Testing at the Time of Diagnosis of Diabetes Could Help Prevent Its Micro- and Macrovascular Complications (2018) (2)
- W09-P-021 New pharmacogenetic model of glucocorticoid-induced dyslipidemia and insulin resistance (2005) (2)
- Na+/H+ exchange in vascular smooth muscle cells is controlled by GTP-binding proteins. (1998) (2)
- 22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts (2015) (2)
- 2B.07: DIASTOLIC BLOOD PRESSURE MODIFIES THE ASSOCIATION OF URIC ACID WITH ALBUMIN/CREATININE RATIO IN PRE-METABOLIC SYNDROME (2015) (1)
- 000 UTILITY OF SEMI-AUTOMATED CLINIC AND 24 HOUR AMBULATORY BLOOD PRESSURE MEASUREMENTS TO EVALUATE FIXED-DOSE COMBINATION THERAPY : THE RAMIPRIL-HYDROCHLOROTHIAZIDE HYPERTENSION TRIAL (2008) (1)
- Novel genetic approaches to the resolution of complex diseases. (2004) (1)
- Minoxidil in severe hypertension (1978) (1)
- Response to Letter to the Editor entitled Oxidative Stress Participates in the Associations Between Serum Uric Acid and Albuminuria in Obesity. (2017) (1)
- ANTISENSE OLIGODEOXYNUCLEOTIDE FOR TRANSFORMING GROWTH FACTOR β1 MODULATES CELL PROLIFERATION AND APOPTOSIS IN VASCULAR SMOOTH MUSCLE CELLS: 6B.5 (2000) (1)
- OS 36-01 HCaRG IMPROVES TISSUE REPAIR AFTER RENAL INJURY BY REGULATING EGFR SIGNALING (2016) (1)
- Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all‐cause mortality in individuals with type 2 diabetes in the ADVANCE trial (2020) (1)
- Introduction: Every Individual Is Different and Precision Medicine Offers Options for Disease Control and Treatment (2017) (1)
- Hypertension in French Canadians Gene Locus in Obesity and Obesity-Associated α Role of Tumor Necrosis Factor (2000) (1)
- Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality (2022) (1)
- [Hypertension: are genes affected by the environment?. Interview by Robert Henry]. (1988) (1)
- P-530: Major loci on rat chromosomes 3, 8 and 17 determine body weight, insulin and triglyceride levels in a model of metabolic syndrome (2003) (1)
- Extraglandular venous circulation of the hypophysis cerebri in the Macaca mulatta. (1967) (1)
- The Sp Transcription Factor Family Is Involved in the Cellular Expression of the Human GIP‐R Gene Promoter (2004) (1)
- Cyclic nucleotides and calmodulin-phosphodiesterase activator: potential biochemical markers of salt sensitivity. (1991) (1)
- COMPREHENSIVE GENE EXPRESSION AND METABOLIC ANALYSIS OF A COMPLEX GENE-ENVIRONMENT INTERACTION AMONG ROSIGLITAZONE, HIGH-FAT-HIGH-CHOLESTEROL DIET AND A RAT CHROMOSOME 4: P1.188 (2004) (1)
- Cyclic nucleotides and platelet aggregation in hypertensive rats with ectopic pituitary tumor. (1980) (1)
- New approaches for the prevention of vascular disease in Type 2 diabetes (2008) (1)
- Concentration of Cyclic AMP in Uremic Man (1975) (1)
- Radiation-inactivation analysis of multidomain proteins: the case of particulate guanylyl cyclase. (1991) (1)
- Vasocare® therapy protects kidney from ischemia/reperfusion-induced damage in the rat (1998) (1)
- Selected abstracts submitted to the Third International Symposium on Hereditary Breast and Ovarian Cancer (2009) (1)
- An activation of NHE1 isoform of Na+/H+ exchanger in primary hypertension: Role of GTP-binding proteins (1998) (1)
- Gastrointestinal peptides and neoplasia ectopic gastric inhibitory polypeptide (GIP) receptors in adrenal glands causing food-dependent Cushing's syndrome (1993) (1)
- Restriction Fragment Length Polymorphism of hsp 70 Gene , Localized in the RT 1 Complex , Is Associated With Hypertension in Spontaneously Hypertensive Rats (2005) (1)
- Increased Na+/Li+ countertransport in erythrocytes of patients with essential hypertension is not caused by activation of Na+,Pi cotransport (2010) (1)
- Heritability of Heart Rate upon Stimulation in Members of Families with History of Hypertension (2000) (1)
- OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY (2016) (1)
- IDENTIFICATION OF GENES DETERMINING THE DIET-INDUCED METABOLIC SYNDROME IN THE RAT: GENE-EXPRESSION PROFILING (2004) (1)
- Pharmacodynamics of Infusions of ANF in Normotensive and Hypertensive Subjects (1986) (1)
- D3 Can we use red blood cells (RBC) for the study of the ubiquitous and renal specific forms of Na+/H+ exchanger in essential hypertension? (1997) (1)
- Increased Na+/Li+ exchange in erythrocytes of patients with essential hypertension is not caused by activation of Na+,P i cotransport (2010) (1)
- Is atrial natriuretic factor anf a ganglionic neurotransmitter (1989) (1)
- Endotoxin response in spontaneously hypertensive rats: a role of the TNFalpha-gene region. (1999) (1)
- Celastrol as a Novel Cardioprotective Drug (2013) (1)
- [BETWEEN USAGE AND POLEMIC, AN ARGUMENT IN FAVOUR OF CLARIFYING THE TERMINOLOGY FOR PREIMPLANTATION GENETIC DIAGNOSIS]. (2015) (1)
- Peptidergic and neurogenic control in high blood pressure. Symposium of the Canadian Federation of Biological Societies. Québec, Québec, Canada, June 17, 1988. Proceedings. (1989) (1)
- An aldosterone stimulating agent: a novel human pituitary hormone from pro-opiomelanocortin. (1981) (1)
- Genetic and biochemical determinants of abnormal ion transport in primary hypertension (invited review (1999) (1)
- YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES. (2016) (1)
- Survey of primary care physicians’ views about breast and ovarian cancer screening for true BRCA1/2 non-carriers (2019) (1)
- Gene–environment interactions: Fundamentals of ecogenetics. By Costa LG, Eaton DL, editors. Hoboken, NJ: John Wiley & Sons, 2006. 450 p. ISBN: 0-471-46781-2.† (2007) (0)
- RESOLUTION OF COMPLEX TRAIT OF HYPERTENSION BY LINKAGE, SYSTEMATIC ALLELIC CONTRIBUTION ANALYSIS AND ANCESTRAL DATA IN FRENCH-CANADIAN FAMILIES: 1B.3 (2004) (0)
- [Hypertension: pathogenetic factors, evaluation and risk factors]. (1981) (0)
- In vivo mapping of receptors with radiolabelled peptides by gamma scintigraphy (1992) (0)
- Theodore Allen Kotchen, MD: June 27, 1938-July 6, 2021. (2021) (0)
- The kidney's primary role in therapeutics and pathogenesis of hypertension. (1989) (0)
- [Corticoadrenal insufficiency (Addison's disease)]. (1984) (0)
- Cover Image, Volume 23, Issue 8 (2021) (0)
- Effect of Upright Posture on Cyclic AMP Excretion in Control Subjects and Patients with Essential Hypertension (1972) (0)
- Contents Vol. 37, 2000 (2000) (0)
- PURINERGIC INHIBITION OF RENAL Na,K,CI COTRANSPORT: A NOVEL SIGNALING PATHWAY LIMITED TO INTERCALATED CELLS FROM COLLECTING DUCTS (2000) (0)
- 34 AUGMENTED RENAL ENAC EXPRESSION AND ACTIVITY CORRELATE WITH AGE-DEPENDENT DEVELOPMENT OF HYPERTENSION IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS (SHR) (2012) (0)
- 1645-P: Polygenic Risk Score for Prediction of Complications in Men and Women with Type 2 Diabetes (2020) (0)
- PDB54 ECONOMIC EVALUATION OF A NEW POLYGENIC RISK SCORE TO PREVENT NEPHROPATHIES IN TYPE-2 DIABETIC PATIENTS (2019) (0)
- sympathoneural response to stress Mapping of genetic determinants of the (2015) (0)
- PRIMARY PREVENTION OF CORONARY HEART DISEASE IN HYPERTENSION. DISCUSSION (1996) (0)
- Assessement of a possible relation between osteoporosis and hypertension in spontaneously hypertensive rats and recombinant inbred strains (2011) (0)
- Author response for "Variability in eGFR and the risk of major clinical outcomes in diabetes: post‐hoc analysis from the ADVANCE trial" (2021) (0)
- O-29 An ethical argument in favor of introducing the discussion of preimplantation genetic diagnosis into consultations for hereditary cancer syndromes (2013) (0)
- Salt and gene expression: evidence for [Na+]i/[K+]i-mediated signaling pathways (2014) (0)
- P-320: Guanylyl cyclase crosstalk in spontaneously hypertensive rats (2003) (0)
- [Labile hypertension: hormonal characteristic and implications of the "second messenger"]. (1973) (0)
- Inflammatory Biomarker Levels and The Risk of Vascular Complications and Mortality in Type 2 Diabetes Mellitus (2013) (0)
- Nordic Microcirculation Society: 30th Annual Meeting, Geilo, NorwayJanuary 27–30, 2000 (2000) (0)
- Inflammatory markers and the risk of vascular complications and mortality in type 2 diabetes mellitus (2013) (0)
- Optimal Control in Hypertension : A Focus on the Role of Direct Renin Inhibition in Helping Reach BP Targets (2010) (0)
- Both cell volume changes and Na + i/K + i-sensitivetranscriptome contribute to inflammatory and immune system responses (2013) (0)
- OS 36-01 HCaRG IMPROVES TISSUE REPAIR AFTER RENAL INJURY BY REGULATING EGFR SIGNALING. (2016) (0)
- 798 Hypertensive patients are more at risk of developing osteoporosis and having fractures due to their low bone mineral density (2012) (0)
- Pretreatment to cell death (2000) (0)
- Swelling rather than shrinkage precedes apoptosis in serum-deprived vascular smooth muscle cells (2012) (0)
- Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels (2019) (0)
- VASOCARE??? PREVENTS RENAL ISCHEMIA/REPERFUSION INJURY IN DOGS (1999) (0)
- Epigenome and exposome in prenatal programming: essential components of personalized medicine in need of understanding and development. (2016) (0)
- A genogram at the crossroads of family health and chronic diseases. (2009) (0)
- P-113: Effect of ACE gene I/D polymorphism on hypertension-related traits in french-canadian families (2003) (0)
- [PS 01-20] ROLE OF HCaRG/COMMD5 IN EPITHELIAL-MESENCHYMAL TRANSITION DURING HYPOXIA (2016) (0)
- [Speed of action of fenfluramine on blood glucose levels]. (1983) (0)
- [The search for a sensor of intracellular sodium involved in pathogenesis of hypertensive disease]. (2011) (0)
- Genes involved in vascular smooth muscle cell proliferation (1994) (0)
- How to translate science into community action. (1996) (0)
- Lessons from the ADVANCE Trial: How to Improve T2 Diabetes Prognosis (2010) (0)
- Direct renin inhibition: Mechanistic advantages and disadvantages compared with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers (2008) (0)
- Comments on pathophysiological studies and cyclic nucleotides. (1980) (0)
- Usefulness of the Aldosterone-to-Renin Ratio for Screening Primary Aldosteronism Diastolic Dysfunction in Hypertensive Heart Disease (2003) (0)
- EXTENSIVE PERSONAL EXPERIENCE Are Ectopic or Abnormal Membrane Hormone Receptors Frequently Present in Adrenal Cushing’s Syndrome?* (2000) (0)
- President ’ s Report 1999-2000 Buy-in from Patients , Health Care Community is Required for Future Progress Hypertension (2001) (0)
- [Involvement of cyclic GMP in the physiological and pathological functions of the atrial natriuretic factor]. (1988) (0)
- Congress Committee (1963) (0)
- OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY. (2016) (0)
- Hypertension and Hypogenitalism: Two New Varieties of This Clinical Association. (1970) (0)
- Prevalence, control andawareness ofhighblood pressure amongCanadian adults (1997) (0)
- From Family to Pharmacogenetics (2001) (0)
- ENaC EXPRESSION AND ACTIVITY CORRELATES WITH DEVELOPMENT OF HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATS (2013) (0)
- Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension. (1999) (0)
- Gène de stress dans l'hypertension (1993) (0)
- 757 HYPERTENSION-RELATED, CALCIUM-REGULATED GENE (HCaRG/COMMD5) INHIBITS KIDNEY CANCER DEVELOPMENT: A NOVEL LINK BETWEEN HYPERTENSION AND RISK OF KIDNEY CANCER (2012) (0)
- The treatment of stress and pre-treatment against stress (1998) (0)
- Contribution of the leptin gene in the development of obesity in hypertensive French Canadian (2001) (0)
- [Impact of diabetes mellitus on driving safety]. (1991) (0)
- 10th International Symposium on SHR and Molecular Medicine¶May 2 – 4, 2001, Berlin-Buch (2001) (0)
- Caspase-dependent cell death of non-carmyocytes in losartan-treated SHR (2001) (0)
- Cushing’s Syndrome due to Aberrant Adrenal Hormone Receptors (2003) (0)
- Participate Guanylate Cyclase: Target Enzyme for ANF (1986) (0)
- Aberrant Hormone Receptors (2002) (0)
- Invitations for the Program: 6th International Congress of Pathophysiology, "Gene-environmental Interactions in Health and Diseases", Montréal, Québec, Canada, 27-30 June 2010. (2008) (0)
- INTRACELLULAR Na+/K+ RATIO AND cAMP SIGNALLING: TWO DISTINCT APPROACHES FOR INTERVENTION IN VASCULAR SMOOTH MUSCLE APOPTOSIS P1.232 (2000) (0)
- CHINESE CONTRIBUTION TO TRIALS ON ANTIHYPERTENSIVE THERAPY. DISCUSSION (1996) (0)
- Concluding Remarks (1991) (0)
- [The adrenergic nervous system and essential arterial hypertension]. (1973) (0)
- PCV6: AVAPROMISE: A RANDOMIZED CLINICAL TRIAL FOR INCREASING COMPLIANCE THROUGH BEHAVIORAL MODIFICATION IN ESSENTIAL HYPERTENSION (2001) (0)
- [Functional hypoglycemia]. (1983) (0)
- F3: Genetic determinants of left ventricular mass in African Americans (1997) (0)
- Literature Abstracts (2001) (0)
- Subject Index Vol. 37, 2000 (2000) (0)
- 82 Stress genes in hypertension (1993) (0)
- Genome-wide scan for linkage to obesity-associated hypertension in French canadians. Commentary (2005) (0)
- [OP.5A.08] HCARG/COMMD5 IMPROVES KIDNEY REPAIR BY REGULATING EGF RECEPTOR TRAFFICKING (2017) (0)
- ADVANCE Master Meeting I of the ADVANCE Glucose-Lowering Arm (2008) (0)
- A quantitative trait locus for aortic smooth muscle cell number acting independently of blood pressure : implicating the angiotensin receptor AT 1 B gene as a candidate (2005) (0)
- The Atrial Natriuretic Factor Purification, Isolation of the Peptide and of Prepro ANF, and Physiological Studies (1986) (0)
- Atrial natriuretic factor: isolation, identification, biological and pharmacological actions. (1985) (0)
- Genetic mapping of habitual substance use, obesity-related traits, responses to mental and physical stress, and heart rate and blood pressure measurements reveals shared genes that are overrepresented in the neural synapse (2012) (0)
- Extracellular cGMP Is a Biological Marker of ANF (1986) (0)
- DYNAMIC GENETIC LINKAGE OF BLOOD PRESSURE PHENOTYPES: 3C.07 (2011) (0)
- A catalog of genetic loci associated with kidney function from analyses of a million individuals (2019) (0)
- YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES. (2016) (0)
- Hypertension and peptic ulcer. (1971) (0)
- [Hypercalcemia and hypocalcemia]. (1983) (0)
- 2P-0353 Prevalence and geographic distribution of a frequent genotypic combination of hyperapo B in the Quebec population (2003) (0)
- Implications of Atrial Natriuretic Factor (ANF) in the Pathogenesis of Experimental and Human Hypertension (1987) (0)
- SYMPOSIUM: PROGRAMMED CELL DEATH-CLINICAL REALITY AND THERAPEUTIC STRATEGIES Apoptosis in Cardiovascular Remodeling— Effect of Medication (2002) (0)
- CELL AND MOLECULAR PHYSIOLOGY (2004) (0)
- Sattar, N. (2018). Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE (2018) (0)
- HCARG EXPRESSION IS REGULATED BY CALCIUM AND SODIUM IONS: P3.206 (2004) (0)
- Effect of vasogen immune modulation therapy (IMT) in a rat model of acute ischemia/reperfusion (IR) injury (2001) (0)
- L005 Heritability of blood pressure and blood pressure determinants in hypertensive-dyslipidemic African Americans (1998) (0)
- [An excess of dopamine in postsympathectomy orthostatic hypotension. Treatment with a dopa-decarboxylase inhibitor]. (1973) (0)
- Proteomic‐based identification of upstream intermediates of Na+i,K+i‐independent death signaling triggered by interaction of cardiotonic steroids with alpha‐subunit of Na,K‐ATPase (2007) (0)
- The Tnfα-Gene Locus and Body-Weight Response to a High-Fat Diet in Spontaneously Hypertensive Rats (2000) (0)
- No effects of pantoprazole on the pharmacokinetics of rosuvastatin in healthy subjects (2016) (0)
- Effect of Cd36 deficiency on carbohydrate and lipid metabolism is contextually determined by genomic background and reflected in transcriptomic profile (2009) (0)
- 913 COMMON GENETIC BACKGROUND FOR HYPERTENSION, METABOLIC SYNDROME TRAITS AND RESTING HEART RATE IN MICROALBUMINURIC SUBJECTS (2012) (0)
- 733 Differential transcriptomicS of indapamide and hydrochlorothiazide in SHR kidney (2012) (0)
- URINARY UROMODULIN IN A PATHWAY BETWEEN DECREASED URINARY URIC ACID EXCRETION AND ALBUMINURIA (2018) (0)
- Awards of the ESM (2000) (0)
- Influence of atrial natriuretic factor on plasma and urinary cyclic GMP (1986) (0)
- Abstract 1786: Dynamic Effect of Posture on Linkage of Candidate Genes for Blood Pressure Homeostasis and Hypertension (2009) (0)
- Burden of cardiovascular disease in women and men (2007) (0)
- Additively on Dahl Rat Chromosome 2 Multiple Quantitative Trait Loci for Blood Pressure Interacting Epistatically and (2005) (0)
- Renal repair and regeneration: Study of a candidate gene HCaRG (2006) (0)
- Results Mean Values and Heritability Estimates of Obesity Measures in All Siblings (2001) (0)
- Increased plasma epinephrine concentration due to its decreased conjugation in beta-hyperadrenergic essential hypertension. (1981) (0)
- THERMOPROTECTION OF VASCULAR SMOOTH MUSCLE ION TRANSPORTERS: POSSIBLE IMPLICATION OF HEAT STRESS PROTEINS (2000) (0)
- HCaRG increases renal cell migration by a TGF- (cid:1) autocrine loop mechanism (2005) (0)
- Treatment of stress and vorbehandlng against stress (1998) (0)
- Geo-ethnic diversity, hypertension and renal impairment in diabetes: Therapeutic consequences (2016) (0)
- Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing (2019) (0)
- The Gatekeeping Function in Personalized Medicine Initiatives (2017) (0)
- B1 cAMP as a potent inhibitor of apoptosis in vascular smooth muscle cells (VSMC) transfected with E1A-adenovirus (1997) (0)
- Prehypertension in the Era of Personalized Medicine in 2017 (2018) (0)
- P-328: High-fat diet augments cardiac hypertrophy and delays blood pressure recovery from stress in spontaneously hypertensive rat (2003) (0)
- [Research on genes causing hypertension]. (1995) (0)
- Transforming Growth Factor px Expression and Effect in Aortic Smooth Muscle Cells From Spontaneously Hypertensive Rats (1991) (0)
- Application for Membership of the ESM (2000) (0)
- Proteome Analysis and Functional Expression Identify Mortalin as an Antiapoptotic Gene Induced by Elevation of [Na Ratio in Cultured Vascular Smooth Muscle Cells Cellular Biology (2002) (0)
- Epilepsy or diabetes and auto accidents. (1991) (0)
- [Intrinsic and extrinsic factors implicated in cell proliferation of vascular smooth muscle in hypertension and diabetes]. (1990) (0)
- [The stress gene in hypertension]. (1993) (0)
- Research: Epidemiology Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE-ON trials (2020) (0)
- ESM August 2002 (2002) (0)
- Summary of 1993 WHO/ISH guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Guidelines Sub-Committee of WHO/ISH Mild Hypertension Liaison Committee. (1993) (0)
- Theme II: hypertension, drugs, cancer and clinical issues (1999) (0)
- P3A-6 Non-Invasive Micro-Vascular Ultrasound Elastography: Comparisons with M-Mode Strain Measurements in Rat Models of Hypertension (2007) (0)
- Grand Paris: The exceptional line 16 Lot 1 (2019) (0)
- NME7: a new candidate gene for T2DM (2010) (0)
- [Insulin pump and intensive insulin therapy]. (1985) (0)
- Angiotensin II blockade induces mesothelial cell apoptosis in the epicardium (2001) (0)
- [Cholesterolemia, hypertension, diabetes: complex pharmacotherapeutic levels]. (1990) (0)
- Transcriptomic changes in Ca 2+-depleted cells: a major role of elevated intracellular [Na +] i/[k +] i ratio (2013) (0)
- LAYARED FOUNDERS : A NOVEL APPROACH TO INGESTIGATE THE ANCESTRAL TRANSMISSION OF COMPLEX TRAITS (2004) (0)
- Candidate hypertension-related phenotypes (2000) (0)
- 70 17q21.31 CNV DOSE DEPENDENT EFFECT ON THE PREVALENCE OF HYPERTENSION AND DYSLIPIDEMIA COMORBIDITY (2012) (0)
- Candidate genes of hypertension with defective environmental expression* (1995) (0)
- [The insulin pump as treatment of the insulin-dependent diabetic]. (1985) (0)
- ELEVATION OF [NA+]I PROTECTS ENDOTHELIAL CELLS FROM APOPTOSIS TRIGGERED BY [3H]-DECAY-INDUCED DNA DAMAGE (2004) (0)
- Genetic determinants of the dynamics and kinetics of alcohol as an environmental modifier of blood pressure. (2003) (0)
- [Cyclic AMP-dependent protein kinase in blood platelets of rats: activation by prostaglandin E-1]. (1977) (0)
- Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (0)
- APOPTOSIS IN SERUM-DEPRIVED VASCULAR SMOOTH MUSCLE CELLS (VSMC): EVIDENCE FOR CELL VOLUME-INDEPENDENT MECHANISM (2004) (0)
- [Excretion of cyclic AMP in arterial hypertension]. (1973) (0)
- Hunting for genes of hypertension: A novel paradigm (1998) (0)
- [OP.5A.03] NOVEL STRATEGIES TO IMPROVE THE MANAGEMENT OF ALBUMINURIA IN HYPERTENSIVE DIABETIC PATIENTS. (2017) (0)
- Muscle Cells : Evidence for Distinct Modes of Cell Death Protection Against Necrosis but Not Apoptosis by Heat-Stress Proteins in Vascular Smooth (1999) (0)
- D4 - Dietary calcium does not affect altered monovalent ion transport in SHR (1995) (0)
- Rapport Final - Le mmdecin face aux nouvelles technologies dans le domaine mmdical: nouvelles responsabilitts? (Final Report Physicians and Emerging Technologies in the Medical Field: New Responsibilities?) (2012) (0)
- A Large-scale and Extensible Platform for Precision Medicine Research (2019) (0)
- 2. Rapid visualization of atrial natriuretic factor (ANF) kidney receptors using radiolabelled ANF (1992) (0)
- HCARG GENE INCREASES MIGRATION POTENTIAL OF KIDNEY CELLS (2004) (0)
- Sex, Age and Gene Interactions in Cardiometabolic Diseases (2020) (0)
- Abstract MP086: Association Between the Angiotensin-Converting Enzyme-2 Gene and Blood Pressure in a Cohort of Canadian Adolescents (2012) (0)
- Hypertension control : economics and lifestyle issues : proceedings of the official symposia of the World Conference on Hypertension Control, Ottawa, Canada, 21 June, 1995 (1996) (0)
- Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure using Preterax and Diamicron MR. (2010) (0)
- Routine blood pressure lowering and kidney disease in type 2 diabetes (2009) (0)
- 1A.09: DISTINCT GENETIC ARCHITECTURE OF RENAL IMPAIRMENT COMPONENTS IN TYPE 2 DIABETES WITHIN CAUCASIAN POPULATIONS OF CELTO-GERMANIC AND SLAVIC ORIGINS (2015) (0)
- [Hôtel-Dieu of Montreal: it is permitted to dream...]. (1992) (0)
- ENDOTHELIAL CELL DEATH TRIGGERED BY OUABAIN: EVIDENCE FOR NOVEL FUNCTION OF THE NA+,K+−ATPASE. (2004) (0)
- PLATELET GROWTH FACTOR AND VASCULAR COMPLICATIONS OF DIABETES (1981) (0)
This paper list is powered by the following services:
Other Resources About Pavel Hamet
What Schools Are Affiliated With Pavel Hamet?
Pavel Hamet is affiliated with the following schools:
